nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—Quinapril—hypertension	0.115	0.255	CrCtD
Aspartame—Trandolapril—hypertension	0.0947	0.21	CrCtD
Aspartame—Enalapril—hypertension	0.0947	0.21	CrCtD
Aspartame—Lisinopril—hypertension	0.0741	0.165	CrCtD
Aspartame—Ramipril—hypertension	0.0718	0.159	CrCtD
Aspartame—SLC22A11—Bumetanide—hypertension	0.025	0.149	CbGbCtD
Aspartame—SLC22A6—Ethacrynic acid—hypertension	0.0173	0.103	CbGbCtD
Aspartame—SLC22A6—Chlorothiazide—hypertension	0.0173	0.103	CbGbCtD
Aspartame—SLC22A11—Furosemide—hypertension	0.0161	0.0962	CbGbCtD
Aspartame—SLC22A8—Enalapril—hypertension	0.0156	0.093	CbGbCtD
Aspartame—SLC22A8—Bumetanide—hypertension	0.0145	0.0868	CbGbCtD
Aspartame—Enalapril—Captopril—hypertension	0.0113	0.0346	CrCrCtD
Aspartame—SLC22A6—Enalapril—hypertension	0.0108	0.0648	CbGbCtD
Aspartame—SLC22A6—Hydrochlorothiazide—hypertension	0.0103	0.0618	CbGbCtD
Aspartame—SLC22A6—Bumetanide—hypertension	0.0101	0.0605	CbGbCtD
Aspartame—Mitiglinide—Fosinopril—hypertension	0.00993	0.0304	CrCrCtD
Aspartame—SLC22A8—Furosemide—hypertension	0.00936	0.0559	CbGbCtD
Aspartame—Lisinopril—Fosinopril—hypertension	0.00858	0.0263	CrCrCtD
Aspartame—Spirapril—Fosinopril—hypertension	0.00858	0.0263	CrCrCtD
Aspartame—SLC22A6—Captopril—hypertension	0.00811	0.0485	CbGbCtD
Aspartame—Trandolapril—Fosinopril—hypertension	0.00805	0.0247	CrCrCtD
Aspartame—Enalapril—Fosinopril—hypertension	0.00805	0.0247	CrCrCtD
Aspartame—Ramipril—Fosinopril—hypertension	0.00805	0.0247	CrCrCtD
Aspartame—Lisinopril—Moexipril—hypertension	0.00744	0.0228	CrCrCtD
Aspartame—Spirapril—Moexipril—hypertension	0.00744	0.0228	CrCrCtD
Aspartame—Trandolapril—Moexipril—hypertension	0.00698	0.0214	CrCrCtD
Aspartame—Enalapril—Moexipril—hypertension	0.00698	0.0214	CrCrCtD
Aspartame—Ramipril—Moexipril—hypertension	0.00698	0.0214	CrCrCtD
Aspartame—SLC22A6—Furosemide—hypertension	0.00652	0.039	CbGbCtD
Aspartame—Spirapril—Perindopril—hypertension	0.0065	0.0199	CrCrCtD
Aspartame—Phenacemide—Guanfacine—hypertension	0.00649	0.0199	CrCrCtD
Aspartame—SLC22A6—Losartan—hypertension	0.00639	0.0382	CbGbCtD
Aspartame—Spirapril—Quinapril—hypertension	0.00617	0.0189	CrCrCtD
Aspartame—Lisinopril—Quinapril—hypertension	0.00617	0.0189	CrCrCtD
Aspartame—Trandolapril—Perindopril—hypertension	0.0061	0.0187	CrCrCtD
Aspartame—Ramipril—Perindopril—hypertension	0.0061	0.0187	CrCrCtD
Aspartame—Enalapril—Perindopril—hypertension	0.0061	0.0187	CrCrCtD
Aspartame—Spirapril—Benazepril—hypertension	0.00602	0.0185	CrCrCtD
Aspartame—Lisinopril—Benazepril—hypertension	0.00602	0.0185	CrCrCtD
Aspartame—Quinapril—Moexipril—hypertension	0.00591	0.0181	CrCrCtD
Aspartame—Mitiglinide—Trandolapril—hypertension	0.00588	0.018	CrCrCtD
Aspartame—Enalapril—Quinapril—hypertension	0.00578	0.0177	CrCrCtD
Aspartame—Ramipril—Quinapril—hypertension	0.00578	0.0177	CrCrCtD
Aspartame—Trandolapril—Quinapril—hypertension	0.00578	0.0177	CrCrCtD
Aspartame—Ramipril—Benazepril—hypertension	0.00565	0.0173	CrCrCtD
Aspartame—Trandolapril—Benazepril—hypertension	0.00565	0.0173	CrCrCtD
Aspartame—Enalapril—Benazepril—hypertension	0.00565	0.0173	CrCrCtD
Aspartame—Quinapril—Perindopril—hypertension	0.00517	0.0158	CrCrCtD
Aspartame—Lisinopril—Trandolapril—hypertension	0.00508	0.0156	CrCrCtD
Aspartame—Spirapril—Enalapril—hypertension	0.00508	0.0156	CrCrCtD
Aspartame—Spirapril—Trandolapril—hypertension	0.00508	0.0156	CrCrCtD
Aspartame—Lisinopril—Enalapril—hypertension	0.00508	0.0156	CrCrCtD
Aspartame—Lisdexamfetamine—Labetalol—hypertension	0.005	0.0153	CrCrCtD
Aspartame—Quinapril—Benazepril—hypertension	0.00478	0.0147	CrCrCtD
Aspartame—Enalapril—Trandolapril—hypertension	0.00476	0.0146	CrCrCtD
Aspartame—Trandolapril—Enalapril—hypertension	0.00476	0.0146	CrCrCtD
Aspartame—Ramipril—Enalapril—hypertension	0.00476	0.0146	CrCrCtD
Aspartame—Ramipril—Trandolapril—hypertension	0.00476	0.0146	CrCrCtD
Aspartame—TRPV1—vagus nerve—hypertension	0.00456	0.428	CbGeAlD
Aspartame—Mitiglinide—Ramipril—hypertension	0.00445	0.0137	CrCrCtD
Aspartame—Nateglinide—Trandolapril—hypertension	0.00425	0.013	CrCrCtD
Aspartame—Nateglinide—Enalapril—hypertension	0.00425	0.013	CrCrCtD
Aspartame—Quinapril—Labetalol—hypertension	0.00424	0.013	CrCrCtD
Aspartame—Quinapril—Enalapril—hypertension	0.00403	0.0124	CrCrCtD
Aspartame—Quinapril—Trandolapril—hypertension	0.00403	0.0124	CrCrCtD
Aspartame—Spirapril—Lisinopril—hypertension	0.00397	0.0122	CrCrCtD
Aspartame—Spirapril—Ramipril—hypertension	0.00385	0.0118	CrCrCtD
Aspartame—Lisinopril—Ramipril—hypertension	0.00385	0.0118	CrCrCtD
Aspartame—Enalapril—Lisinopril—hypertension	0.00373	0.0114	CrCrCtD
Aspartame—Ramipril—Lisinopril—hypertension	0.00373	0.0114	CrCrCtD
Aspartame—Trandolapril—Lisinopril—hypertension	0.00373	0.0114	CrCrCtD
Aspartame—Lisdexamfetamine—Lisinopril—hypertension	0.00373	0.0114	CrCrCtD
Aspartame—Enalapril—Ramipril—hypertension	0.00361	0.0111	CrCrCtD
Aspartame—Trandolapril—Ramipril—hypertension	0.00361	0.0111	CrCrCtD
Aspartame—Nateglinide—Lisinopril—hypertension	0.00332	0.0102	CrCrCtD
Aspartame—Nateglinide—Ramipril—hypertension	0.00322	0.00987	CrCrCtD
Aspartame—Quinapril—Lisinopril—hypertension	0.00316	0.00968	CrCrCtD
Aspartame—Quinapril—Ramipril—hypertension	0.00306	0.00937	CrCrCtD
Aspartame—SLC22A8—nephron—hypertension	0.00118	0.111	CbGeAlD
Aspartame—SLC22A8—urine—hypertension	0.000949	0.0891	CbGeAlD
Aspartame—SLC22A11—nephron tubule—hypertension	0.000453	0.0425	CbGeAlD
Aspartame—TRPV1—endocrine gland—hypertension	0.000428	0.0401	CbGeAlD
Aspartame—SLC22A6—nephron tubule—hypertension	0.000427	0.0401	CbGeAlD
Aspartame—SLC22A11—kidney—hypertension	0.000398	0.0374	CbGeAlD
Aspartame—SLC22A11—cortex of kidney—hypertension	0.000388	0.0364	CbGeAlD
Aspartame—TRPV1—central nervous system—hypertension	0.000385	0.0362	CbGeAlD
Aspartame—SLC22A6—cortex of kidney—hypertension	0.000365	0.0343	CbGeAlD
Aspartame—Lisinopril—ACE2—hypertension	0.000313	0.153	CrCbGaD
Aspartame—SLC22A11—endocrine gland—hypertension	0.000279	0.0262	CbGeAlD
Aspartame—SLC22A8—nephron tubule—hypertension	0.000255	0.024	CbGeAlD
Aspartame—SLC22A8—kidney—hypertension	0.000225	0.0211	CbGeAlD
Aspartame—SLC22A8—cortex of kidney—hypertension	0.000219	0.0205	CbGeAlD
Aspartame—SLC22A8—central nervous system—hypertension	0.000142	0.0133	CbGeAlD
Aspartame—Lisdexamfetamine—SLC6A2—hypertension	0.000131	0.0641	CrCbGaD
Aspartame—Mitiglinide—KCNJ11—hypertension	0.000128	0.0625	CrCbGaD
Aspartame—L-Phenylalanine—TH—hypertension	9.06e-05	0.0443	CrCbGaD
Aspartame—Dextroamphetamine—SLC6A2—hypertension	7.82e-05	0.0382	CrCbGaD
Aspartame—Spirapril—ACE—hypertension	7.42e-05	0.0362	CrCbGaD
Aspartame—Mitiglinide—PPARG—hypertension	7.08e-05	0.0346	CrCbGaD
Aspartame—Lisdexamfetamine—SLC6A3—hypertension	6.67e-05	0.0326	CrCbGaD
Aspartame—Methamphetamine—ADRA2B—hypertension	6.65e-05	0.0325	CrCbGaD
Aspartame—Quinapril—ACE—hypertension	6.61e-05	0.0323	CrCbGaD
Aspartame—Lisinopril—ACE—hypertension	6.61e-05	0.0323	CrCbGaD
Aspartame—Nateglinide—KCNJ11—hypertension	6.51e-05	0.0318	CrCbGaD
Aspartame—Lacosamide—CA9—hypertension	6.41e-05	0.0313	CrCbGaD
Aspartame—Ramipril—ACE—hypertension	6.4e-05	0.0313	CrCbGaD
Aspartame—Trandolapril—ACE—hypertension	6.4e-05	0.0313	CrCbGaD
Aspartame—Amphetamine—SLC6A2—hypertension	6.31e-05	0.0308	CrCbGaD
Aspartame—Methamphetamine—SLC6A2—hypertension	5.84e-05	0.0286	CrCbGaD
Aspartame—Dextroamphetamine—ADRA1A—hypertension	5.51e-05	0.0269	CrCbGaD
Aspartame—Bortezomib—PTGS1—hypertension	5.19e-05	0.0254	CrCbGaD
Aspartame—Enalapril—ACE—hypertension	4.85e-05	0.0237	CrCbGaD
Aspartame—Bortezomib—CYP1A1—hypertension	4.75e-05	0.0232	CrCbGaD
Aspartame—Dextroamphetamine—SLC6A3—hypertension	3.98e-05	0.0195	CrCbGaD
Aspartame—Nateglinide—PPARG—hypertension	3.61e-05	0.0176	CrCbGaD
Aspartame—Nateglinide—CYP3A5—hypertension	3.59e-05	0.0176	CrCbGaD
Aspartame—Amphetamine—SLC6A3—hypertension	3.21e-05	0.0157	CrCbGaD
Aspartame—Methamphetamine—SLC6A3—hypertension	2.97e-05	0.0145	CrCbGaD
Aspartame—Methamphetamine—ADRA2A—hypertension	2.91e-05	0.0142	CrCbGaD
Aspartame—Nateglinide—PTGS1—hypertension	2.66e-05	0.013	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—OXT—hypertension	2.66e-05	0.000611	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—F2R—hypertension	2.63e-05	0.000604	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFBR1—hypertension	2.63e-05	0.000604	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC8A1—hypertension	2.63e-05	0.000603	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCD—hypertension	2.62e-05	0.000602	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCR5—hypertension	2.62e-05	0.000602	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HTR2A—hypertension	2.57e-05	0.000589	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—C3—hypertension	2.56e-05	0.000589	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SGK1—hypertension	2.56e-05	0.000588	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NCF1—hypertension	2.55e-05	0.000585	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRB—hypertension	2.55e-05	0.000585	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—hypertension	2.53e-05	0.000581	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TAC1—hypertension	2.52e-05	0.000579	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLG—hypertension	2.48e-05	0.000571	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A2—hypertension	2.48e-05	0.00057	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ANXA1—hypertension	2.47e-05	0.000568	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR3—hypertension	2.47e-05	0.000568	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC5A2—hypertension	2.47e-05	0.000566	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A4—hypertension	2.46e-05	0.000565	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IKBKB—hypertension	2.45e-05	0.000562	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGT—hypertension	2.44e-05	0.000559	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SST—hypertension	2.4e-05	0.000552	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRA—hypertension	2.4e-05	0.000552	CbGpPWpGaD
Aspartame—Amphetamine—SLC6A4—hypertension	2.4e-05	0.0117	CrCbGaD
Aspartame—TAS1R2—Signaling by GPCR—CALM1—hypertension	2.39e-05	0.00055	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CYBA—hypertension	2.39e-05	0.00055	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB1—hypertension	2.39e-05	0.00055	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FLT1—hypertension	2.39e-05	0.00055	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DRD3—hypertension	2.39e-05	0.00055	CbGpPWpGaD
Aspartame—Amphetamine—DRD2—hypertension	2.39e-05	0.0117	CrCbGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NEDD4L—hypertension	2.38e-05	0.000547	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC1—hypertension	2.38e-05	0.000547	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—hypertension	2.36e-05	0.000541	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRA2A—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TRPC5—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2B3—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC4A4—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1A2—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1A1—hypertension	2.35e-05	0.00054	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLAT—hypertension	2.34e-05	0.000538	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GHRL—hypertension	2.34e-05	0.000538	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALCA—hypertension	2.31e-05	0.000532	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A3—hypertension	2.31e-05	0.00053	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GNB3—hypertension	2.3e-05	0.000529	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—HMOX1—hypertension	2.29e-05	0.000527	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2B1—hypertension	2.27e-05	0.000522	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—AVP—hypertension	2.27e-05	0.000522	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—CP—hypertension	2.26e-05	0.000519	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BDKRB2—hypertension	2.26e-05	0.000519	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AVPR2—hypertension	2.25e-05	0.000518	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP1B1—hypertension	2.25e-05	0.000518	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—COX5B—hypertension	2.25e-05	0.000518	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCB—hypertension	2.25e-05	0.000517	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—F2—hypertension	2.25e-05	0.000517	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A18—hypertension	2.24e-05	0.000515	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SCNN1A—hypertension	2.24e-05	0.000515	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A19—hypertension	2.24e-05	0.000515	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GNAS—hypertension	2.24e-05	0.000515	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AQP1—hypertension	2.24e-05	0.000514	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2A3—hypertension	2.24e-05	0.000514	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRBK1—hypertension	2.24e-05	0.000513	CbGpPWpGaD
Aspartame—Methamphetamine—SLC6A4—hypertension	2.22e-05	0.0109	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—CNR1—hypertension	2.22e-05	0.00051	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOB—hypertension	2.2e-05	0.000504	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALM2—hypertension	2.2e-05	0.000504	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HTR7—hypertension	2.16e-05	0.000497	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DRD2—hypertension	2.16e-05	0.000497	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTPN1—hypertension	2.14e-05	0.000492	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GCG—hypertension	2.14e-05	0.000492	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC9A3—hypertension	2.14e-05	0.000491	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC12A2—hypertension	2.14e-05	0.000491	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KL—hypertension	2.1e-05	0.000483	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH2—hypertension	2.1e-05	0.000483	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC8A1—hypertension	2.1e-05	0.000482	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—AVP—hypertension	2.09e-05	0.000481	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITGAV—hypertension	2.06e-05	0.000474	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NGFR—hypertension	2.06e-05	0.000474	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KNG1—hypertension	2.06e-05	0.000472	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ADCY5—hypertension	2.05e-05	0.000471	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—POMC—hypertension	2.05e-05	0.000471	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR1—hypertension	2.04e-05	0.00047	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRL—hypertension	2.04e-05	0.00047	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC9—hypertension	2.04e-05	0.000468	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AQP4—hypertension	2.03e-05	0.000465	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STK11—hypertension	2.01e-05	0.000463	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HDAC1—hypertension	2.01e-05	0.000463	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL2—hypertension	2.01e-05	0.000461	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL10—hypertension	2e-05	0.000459	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLG—hypertension	1.99e-05	0.000458	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT2—hypertension	1.97e-05	0.000452	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—hypertension	1.97e-05	0.000452	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SGK1—hypertension	1.95e-05	0.000449	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TRPC3—hypertension	1.94e-05	0.000446	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB2—hypertension	1.94e-05	0.000445	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—hypertension	1.93e-05	0.000443	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCE—hypertension	1.91e-05	0.00044	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VAV3—hypertension	1.89e-05	0.000434	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFA—hypertension	1.89e-05	0.000434	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AVPR2—hypertension	1.88e-05	0.000432	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC5A2—hypertension	1.88e-05	0.000432	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—COX5B—hypertension	1.88e-05	0.000432	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hypertension	1.88e-05	0.000432	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—hypertension	1.88e-05	0.000431	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFBR2—hypertension	1.86e-05	0.000428	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PPARA—hypertension	1.85e-05	0.000425	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNB3—hypertension	1.85e-05	0.000424	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AVP—hypertension	1.82e-05	0.000418	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC1—hypertension	1.82e-05	0.000417	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NEDD4L—hypertension	1.82e-05	0.000417	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RHOA—hypertension	1.81e-05	0.000415	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CP—hypertension	1.8e-05	0.000415	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNAS—hypertension	1.8e-05	0.000413	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3R1—hypertension	1.79e-05	0.000411	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC9A3—hypertension	1.78e-05	0.000409	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC12A2—hypertension	1.78e-05	0.000409	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOB—hypertension	1.76e-05	0.000404	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A3—hypertension	1.76e-05	0.000404	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTK2—hypertension	1.75e-05	0.000403	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOA1—hypertension	1.74e-05	0.000399	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDN1—hypertension	1.73e-05	0.000398	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2B1—hypertension	1.73e-05	0.000398	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL5—hypertension	1.72e-05	0.000395	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2A3—hypertension	1.71e-05	0.000392	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AQP1—hypertension	1.71e-05	0.000392	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC9—hypertension	1.7e-05	0.000391	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LPL—hypertension	1.68e-05	0.000386	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—H2AFX—hypertension	1.67e-05	0.000383	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RPS6KB1—hypertension	1.67e-05	0.000383	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFRB—hypertension	1.67e-05	0.000383	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADCY5—hypertension	1.65e-05	0.000378	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCG—hypertension	1.63e-05	0.000376	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SGK1—hypertension	1.63e-05	0.000375	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITGB3—hypertension	1.62e-05	0.000373	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCA—hypertension	1.62e-05	0.000373	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—hypertension	1.61e-05	0.00037	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—YWHAZ—hypertension	1.61e-05	0.00037	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC8A1—hypertension	1.6e-05	0.000367	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—AVP—hypertension	1.6e-05	0.000367	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NGF—hypertension	1.59e-05	0.000366	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPP1—hypertension	1.59e-05	0.000366	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL8—hypertension	1.59e-05	0.000364	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC9A1—hypertension	1.57e-05	0.000361	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC5A2—hypertension	1.57e-05	0.000361	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—hypertension	1.57e-05	0.00036	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CETP—hypertension	1.55e-05	0.000356	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCD—hypertension	1.55e-05	0.000356	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCR5—hypertension	1.55e-05	0.000356	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AQP4—hypertension	1.54e-05	0.000355	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HTR2A—hypertension	1.52e-05	0.000348	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC1—hypertension	1.52e-05	0.000348	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NEDD4L—hypertension	1.52e-05	0.000348	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—C3—hypertension	1.51e-05	0.000348	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TRPC3—hypertension	1.48e-05	0.00034	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFB—hypertension	1.47e-05	0.000338	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A3—hypertension	1.47e-05	0.000337	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR1—hypertension	1.47e-05	0.000337	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2B1—hypertension	1.45e-05	0.000332	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—hypertension	1.44e-05	0.000332	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGT—hypertension	1.44e-05	0.00033	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2A3—hypertension	1.43e-05	0.000327	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AQP1—hypertension	1.43e-05	0.000327	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALM1—hypertension	1.41e-05	0.000325	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEP—hypertension	1.41e-05	0.000324	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOE—hypertension	1.41e-05	0.000324	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CAV1—hypertension	1.4e-05	0.000321	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOA1—hypertension	1.39e-05	0.00032	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KDR—hypertension	1.38e-05	0.000317	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CP—hypertension	1.38e-05	0.000316	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—hypertension	1.38e-05	0.000316	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLAT—hypertension	1.37e-05	0.000314	CbGpPWpGaD
Aspartame—Nateglinide—ALB—hypertension	1.36e-05	0.00663	CrCbGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC8A1—hypertension	1.33e-05	0.000307	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—AVP—hypertension	1.33e-05	0.000306	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—F2—hypertension	1.33e-05	0.000305	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FN1—hypertension	1.33e-05	0.000305	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCB—hypertension	1.33e-05	0.000305	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH1—hypertension	1.3e-05	0.000299	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AQP4—hypertension	1.29e-05	0.000296	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC6A3—hypertension	1.29e-05	0.000295	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—hypertension	1.27e-05	0.000291	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A4—hypertension	1.25e-05	0.000287	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TRPC3—hypertension	1.24e-05	0.000284	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—POMC—hypertension	1.21e-05	0.000278	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—INS—hypertension	1.2e-05	0.000277	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC9A1—hypertension	1.2e-05	0.000275	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL2—hypertension	1.18e-05	0.000272	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CETP—hypertension	1.18e-05	0.000272	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1—hypertension	1.16e-05	0.000267	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT2—hypertension	1.16e-05	0.000267	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLG—hypertension	1.16e-05	0.000267	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—hypertension	1.16e-05	0.000266	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CP—hypertension	1.15e-05	0.000264	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SERPINE1—hypertension	1.11e-05	0.000254	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GNB3—hypertension	1.08e-05	0.000248	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HMOX1—hypertension	1.07e-05	0.000247	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF2—hypertension	1.07e-05	0.000246	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RHOA—hypertension	1.07e-05	0.000245	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AVP—hypertension	1.06e-05	0.000244	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOS3—hypertension	1.06e-05	0.000243	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3R1—hypertension	1.06e-05	0.000243	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GNAS—hypertension	1.05e-05	0.000241	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLAT—hypertension	1.04e-05	0.00024	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOB—hypertension	1.03e-05	0.000236	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC9A1—hypertension	9.99e-06	0.00023	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RELA—hypertension	9.94e-06	0.000228	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CETP—hypertension	9.88e-06	0.000227	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC6A3—hypertension	9.81e-06	0.000225	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MTOR—hypertension	9.75e-06	0.000224	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—hypertension	9.67e-06	0.000222	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ADCY5—hypertension	9.61e-06	0.000221	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A4—hypertension	9.54e-06	0.000219	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL8—hypertension	9.37e-06	0.000215	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—hypertension	8.91e-06	0.000205	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLG—hypertension	8.87e-06	0.000204	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLAT—hypertension	8.71e-06	0.0002	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PPARA—hypertension	8.67e-06	0.000199	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—hypertension	8.47e-06	0.000195	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1A—hypertension	8.44e-06	0.000194	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTEN—hypertension	8.42e-06	0.000193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK8—hypertension	8.24e-06	0.000189	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GNB3—hypertension	8.22e-06	0.000189	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—hypertension	8.22e-06	0.000189	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HMOX1—hypertension	8.19e-06	0.000188	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A3—hypertension	8.19e-06	0.000188	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOA1—hypertension	8.13e-06	0.000187	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AVP—hypertension	8.11e-06	0.000186	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—hypertension	8.07e-06	0.000185	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EP300—hypertension	8.03e-06	0.000184	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GNAS—hypertension	8.01e-06	0.000184	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A4—hypertension	7.96e-06	0.000183	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOB—hypertension	7.84e-06	0.00018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SRC—hypertension	7.81e-06	0.000179	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—hypertension	7.61e-06	0.000175	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLG—hypertension	7.4e-06	0.00017	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ADCY5—hypertension	7.33e-06	0.000168	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—hypertension	7e-06	0.000161	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—hypertension	6.98e-06	0.00016	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GNB3—hypertension	6.86e-06	0.000158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—hypertension	6.85e-06	0.000157	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HMOX1—hypertension	6.83e-06	0.000157	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AVP—hypertension	6.77e-06	0.000156	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GNAS—hypertension	6.68e-06	0.000153	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PPARA—hypertension	6.61e-06	0.000152	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOB—hypertension	6.54e-06	0.00015	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—hypertension	6.45e-06	0.000148	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOA1—hypertension	6.2e-06	0.000142	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ADCY5—hypertension	6.12e-06	0.000141	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TP53—hypertension	5.75e-06	0.000132	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PPARA—hypertension	5.52e-06	0.000127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—hypertension	5.26e-06	0.000121	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOA1—hypertension	5.18e-06	0.000119	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—hypertension	4.92e-06	0.000113	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—hypertension	4.85e-06	0.000111	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—hypertension	4.1e-06	9.42e-05	CbGpPWpGaD
